@NIHgov & @NIAID are building on existing coronavirus research for a truly unparalleled timeline for starting clinical trials for treatments, diagnostic tests, and vaccine candidates. We have also produced findings on how long the virus lives on various surfaces; expanded access to coronavirus literature through PubMed; created a program to train #COVID19 workers to protect their own health; teamed up with FDA and the VA to accelerate the production of 3-D printed supplies for #COVID19; developed treatment guidelines with an expert panel; started a serology study to quantify undetected infections in the US; and so much more.
Some major research milestones I would like to highlight are shown in the images above. We started the first vaccine candidate trial on March 16. Among our treatment clinical trials, we found that remdesivir seems to help very sick, hospitalized people recover faster. We are planning a partnership with pharma companies, Federal partners, and academic experts called ACTIV: Accelerating #COVID19 Therapeutic Interventions and Vaccines. One of the goals of ACTIV is to comb through therapeutic candidates to prioritize those with the most promise to enter a clinical trial, while working to standardize evaluation methods to speed FDA review. We still need more diagnostic tests to help us all return safely to public spaces. To that end, #NIH launched a #COVID19 initiative called Rapid Acceleration of Diagnostics, or RADx, just a few weeks ago. Its goal is to be able to develop millions of diagnostic tests per week to help Americans return to their normal lives. RADx includes a competition calling on American ingenuity to develop accessible, safe, fast & effective tests. In one week, NIH received 1087 applicants. One component of RADx, called RADx-UP, focuses on implementation of strategies to enable testing of rural, underserved, and under-resourced populations - some of the hardest hit communities. While I could easily go on and on, suffice it to say that we are hard at work researching ways to combat this virus.
@NIHgov @NIAID #NIAID #COVID19 #Research #PassTheMic @ONE